does reimbursement actually matter or is it forum lore at this point
Trying to get a straight answer on this: does reimbursement actually matter or is it forum lore at this point.
The variation between pharmacies inside my own country was larger than the variation I had been chasing across the border.
Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them.
Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.
Would rather be corrected in public than confident in private.
best — the order this archive was captured in
Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.
[deleted]
a shortage in one member state is not a shortage in all of them
Are you comparing the same presentation, or different pack sizes?
Small fix — those two prices are for different pack sizes, which accounts for most of the gap.
Is this a cross-border question or a domestic one?
Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.
The translation cost of dealing with a foreign pharmacy was the thing I had not budgeted for.
Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.
Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.
Compared prices across two neighbouring countries and found the difference was mostly pack size once I normalised it.
Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.